Chondrosarcoma of the spine: A rare case with unusual presentation by Panelos, John et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Diagnostic Pathology
Open Access Case Report
Chondrosarcoma of the spine: A rare case with unusual 
presentation
John Panelos1, Spyridon Voulgaris2, Evangelos Michos2, Michael Doukas1, 
Konstantinos Charalabopoulos3 and Anna Batistatou*1
Address: 1Department of Pathology University of Ioannina Medical School, Ioannina, Greece, 2Department of Neurosurgery, University of 
Ioannina Medical School, Ioannina, Greece and 3Department of Physiology, Clinical Unit, University of Ioannina Medical School, Ioannina, 
Greece
Email: John Panelos - jpanel@cc.uoi.gr; Spyridon Voulgaris - svoulg@cc.uoi.gr; Evangelos Michos - abatista@cc.uoi.gr; 
Michael Doukas - abatista@cc.uoi.gr; Konstantinos Charalabopoulos - kcharala@cc.uoi.gr; Anna Batistatou* - abatista@cc.uoi.gr
* Corresponding author    
Abstract
Chondrosarcoma is the third most common primary malignancy of bone, affecting primarily the
pelvic and shoulder girdles and being extremely rare in the spine. Herein, we present a case of a
65-year-old woman with a rare chondrosarcoma of the spine, who presented with clinical
symptoms from the lung metastasis. The neoplasm was grade II and exhibited overexpression of
the p53 tumor suppressor protein. The latter has been associated with a high propensity for distant
metastases.
Background
Chondrosarcoma is a malignant tumor composed entirely
of hyaline cartilage matrix and chondrocytes [6,12]. It is
the third most common primary malignant neoplasm of
bone after myeloma and osteosarcoma. The majority of
patients are older than 50 years, with a peak of incidence
in the fifth to seventh decade of life. More than two thirds
of cases involve the bones of the pelvis, the shoulder and
the proximal ends of femur and humerus [12]. Chondro-
sarcoma is extremely rare in the spine [1,10,11].
Case Presentation
A 65-year-old woman, non smoker, visited our hospital
with a 6-month history of persistent dry cough. Radio-
graphic examination revealed the presence of a solitary
nodule of the lung (right upper field), with morphologic
features more consistent with metastasis. The patient
mentioned a persistent, mild lumbar pain for the last two
years and she had received nonsteroidal anti-inflamma-
tory drugs. Upon a detailed physical examination a barely
palpable mass at the lumbar area was noted. The reflexes
of the lower extremities were normal. Laboratory exami-
nation showed no abnormalities, and all tumor markers
had normal values. Magnetic resonance imaging (MRI)
and CT-scan revealed an ill-defined osteolytic lesion of
the L 5 vertebra with a splotch calcification, cortical per-
meation and extension to the surrounding soft tissues. In
chest CT-scan the lung nodule was of similar consistency.
An attempt to biopsy the lung nodule was made, but the
material obtained was insufficient for diagnosis.
The patient underwent surgery in the spine, due to the
danger of collapse of the L5 vertebra and the mass was
exsiced.
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The histopathological examination revealed a moderately
cellular multilobular neoplasm with chondroid and
myxoid matrix and focal necrosis. Under high power
view, multicellular lacunae of chondrocytes with moder-
ate nuclear pleomorphism and hypercromasia were
observed (Fig. 1). Mitotic figures were numerous. The
tumor was diagnosed as chondrosarcoma, grade II. On
immunohistochemical examination > 25 % of the neo-
plastic cells exhibited nuclear immunoreactivity for the
tumor suppressor protein p53 (Fig. 2). Furthermore < 1 %
of the neoplastic cells were in cell cycle, as estimated with
the immunohistochemical marker MIB-1 (ki-67) (Fig. 3).
The patient underwent radiotherapy and is alive one year
later.
Discussion
The incidence of chondrosarcoma of the spine is reported
to be 4–10% of all chondrosarcomas and 12% of all
malignant neoplasms of the spine [1,10,11]. The main
symptom is pain and sensory or motor deficit. The diag-
nosis is difficult, particularly from needle biopsy material,
therefore open biopsy is recommended. The microscopic
features of chondrosarcoma of the spine are similar with
those of the most common appendicular tumors.
Chondrosarcomas are locally aggressive tumors with lim-
ited potential for metastasis. When metastases occur, they
generally involve the lungs and appear late in the course
of the disease. Wide surgical resection is the treatment of
choice. Chondrosarcomas are divided into three grades
according to the nuclear size, nuclear staining (hypercro-
masia) and cellularity [4]. Many studies have shown the
significance of grading of chondrosarcoma in predicting
Multilobular neoplasm with chondroid matrix and nuclear pleiomorphism (haematoxylin and eosin X400) Figure 1
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the tumor behaviour and prognosis. Indeed, histological
grade is the most important single predictor of local recur-
rence and metastasis.
Cytogenetic analyses have demonstrated a strong correla-
tion between chromosomal abnormalities and histologic
grade. Of the proto-oncogenes only the c-met gene which
encodes for a transmembrane tyrosine kinase has been
shown to be associated with the development of cartilag-
inous tumors [13]. Of the tumor suppressor genes, several
studies have shown that altered patterns of p53 expression
and TP53 mutations are detected primarily in high-grade,
advanced tumors. The TP53 gene appears to be inacti-
vated late in the course of chondrosarcoma and may be
associated with disease progression. [2,3,7,12]. Altered
p53 status has been correlated with high propensity for
local recurrence and distant metastases even in grade I and
grade II chondrosarcomas, indicating that it may repre-
sent a predictor of aggressive behavior that is independent
of grade [8]. Furthermore, in a recent study, overexpres-
sion of p53 and Ki-67 in high-grade chondrosarcomas has
been correlated with an unfavorable outcome [5]. The
development and progression of malignant neoplasms
has been associated with the production of different mol-
ecules, such as growth factors, that can be identified as
biological markers as well. In chondrosarcomas, besides
p53 and Ki-67, the expression of growth factors, i.e. TGFβ
and PDGF and of VEGF has been associated with more
aggressive behavior [5].
This is the first report on the p53 expression in a spinal
chondrosarcoma. It is interesting that in our case, which
presented initially with symptomatology from the lung
metastasis, we noted p53 immunostaining in a high per-
centage of neoplastic cells. Thus, it appears that in spinal
chondrosarcomas, similar to the appendiceal ones, the
Increased nuclear immunoreactivity for p53 (DABX400) Figure 2
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metastatic potential may be correlated with altered p53
status. Further studies, with a series of spinal chondrosar-
comas and possibly with the use of tissue microarrays [9]
are needed for definite conclusions.
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